Abstract
Uncontrolled canonical Wnt signalling supports colon epithelial tumour expansion and malignant transformation. Understanding the regulatory mechanisms involved is crucial for elucidating the pathogenesis of and will provide new therapeutic targets for colon cancer. Epsins are ubiquitin-binding adaptor proteins upregulated in several human cancers; however, the involvement of epsins in colon cancer is unknown. Here we show that loss of intestinal epithelial epsins protects against colon cancer by significantly reducing the stability of the crucial Wnt signalling effector, dishevelled (Dvl2), and impairing Wnt signalling. Consistently, epsins and Dvl2 are correspondingly upregulated in colon cancer. Mechanistically, epsin binds Dvl2 via its epsin N-terminal homology domain and ubiquitin-interacting motifs and prohibits Dvl2 polyubiquitination and degradation. Our findings reveal an unconventional role for epsins in stabilizing Dvl2 and potentiating Wnt signalling in colon cancer cells to ensure robust colon cancer progression. The pro-carcinogenic role of Epsins suggests that they are potential therapeutic targets to combat colon cancer.
Original language | English (US) |
---|---|
Article number | 6380 |
Journal | Nature communications |
Volume | 6 |
DOIs | |
State | Published - Mar 16 2015 |
Funding
We thank Dr Kirk Bergstrom in Dr Lijun Xia’s laboratory in our department and Dr Bruce Vallance at the University of British Columbia in Canada, for sharing the CMT-93 cell line. We also thank the Oklahoma Medical Research Foundation imaging core for help with the histological studies. This work was supported in part by NIH grants R01HL-093242, R01HL-118676, P20 RR018758, a National Scientific Development Grant from the American Heart Association (AHA; 0835544N), grant from the Oklahoma Center for Advanced Science and Technology (OCAST) HR09-116 and a grant from the Department of Defense W81XWH-11-1-00226 to H.C.; NIH grants R01DK085691 and P01HL-085607 to L.X.; grants from OCAST AR11-043 and AH14-056 and from AHA-SDG 12SDG8760002 to Y.D.; AHA Postdoctoral fellowships 13POST16940008 to K.L.T. and 13POST17270006 to S.P.; AHA Predoctoral fellowship RSRCH016952 to X.L.
ASJC Scopus subject areas
- General Physics and Astronomy
- General Chemistry
- General Biochemistry, Genetics and Molecular Biology